Maxim Partners Growth Investment in KGK Science Inc
July 27, 2026
KGK Science Inc. received a growth investment led by Maxim Partners to expand its clinical research and regulatory capabilities. The transaction closed on June 30, 2026, and financial terms were not disclosed.
- Buyers
- Maxim Partners
- Targets
- KGK Science Inc.
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
GHO Capital Partners Acquires Scientist.com
November 20, 2025
Cloud & SaaS
GHO Capital Partners LLP acquired Scientist.com, the AI-enabled R&D orchestration platform for life sciences, in a deal intended to accelerate global scale and technology development. Scientist.com will expand platform adoption (including across Europe) and invest in next-generation AI/automation capabilities for outsourced R&D procurement and compliance workflows.
-
TPG Growth Makes Strategic Growth Investment in K2 Medical Research
June 17, 2024
Healthcare Services
TPG (TPG Growth) has made a strategic growth investment in K2 Medical Research to partner with management and scale K2’s integrated clinical trial site platform. K2, headquartered in the Orlando/Maitland, Florida area, operates several de novo sites focused on CNS and other complex therapeutic-area trials and has participated in more than 150 studies for over 35 pharma and biotech sponsors; terms were not disclosed.
-
KKR Makes Growth Investment in FGS Global
April 11, 2023
Consulting
KKR has made a growth investment in FGS Global, the strategic advisory and communications consultancy in which WPP remains the majority shareholder. Golden Gate Capital will exit its stake to KKR; the transaction values FGS Global at $1.425 billion and is expected to close before the end of Q3 2023.
-
KKR Makes Minority Investment in SkinSpirit
October 20, 2022
Healthcare Services
KKR has made a minority growth investment in SkinSpirit, a U.S. medical‑aesthetics and medical‑spa platform, to accelerate national expansion and talent development while founder Lynn Heublein remains in leadership. GreyLion, an earlier investor, will remain a minority owner as KKR invests through its Health Care Strategic Growth Fund II to support scaling the business.
-
LLR Partners Makes Growth Investment in Genesee Scientific
October 19, 2021
Medical Devices
LLR Partners completed a growth investment in Genesee Scientific, a San Diego–based manufacturer and distributor of life-science consumables and laboratory equipment. The partnership will fund expansion of Genesee's product portfolio and scaling of its national footprint; Audax Private Debt provided unitranche financing to support the transaction.
-
Kinderhook Industries Invests in StudyKIK
March 8, 2018
Healthcare Services
Kinderhook Industries announced a growth investment in StudyKIK, partnering with founders Matt Miller and Jerome Chiaro to accelerate the patient-recruitment company's growth. StudyKIK, headquartered in Costa Mesa, California, provides social-media-driven patient recruitment and retention solutions for clinical trials and will work with Kinderhook to scale its technology and market penetration.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.